BiotechTube
ViaDerma

ViaDerma

Los Angeles, United States· Est.
getvitastem.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $10M

Overview

ViaDerma is a private, commercial-stage company focused on the generic drug sector, specifically topical antibiotics. Its core asset is VitaStem, an OTC product powered by proprietary SkinPass™ technology for rapid transdermal delivery of tetracycline hydrochloride. The company targets the consumer health and professional wound care markets with claims of faster healing and superior germ-killing efficacy compared to traditional topicals like bacitracin and Neosporin. It operates as a direct-to-consumer and likely B2B business from Los Angeles.

Wound CareDermatologyInfectious Disease

Technology Platform

Patented SkinPass™ transdermal delivery technology designed for rapid absorption of topical antibiotics through skin layers to target infection at the source.

Funding History

3
Total raised:$10M
Debt$2M
Series A$6.5M
Seed$1.5M

Opportunities

The large and growing chronic wound care market, particularly for diabetic ulcers, presents a significant opportunity if VitaStem can generate clinical evidence for these off-label uses.
Rising concerns about antibiotic resistance and MRSA also create demand for products claiming efficacy against resistant bacteria.

Risk Factors

Substantial regulatory risk from marketing off-label uses for serious conditions without FDA approval.
Intense competition from entrenched, well-capitalized OTC brands and a lack of published, peer-reviewed clinical data to support superior efficacy claims.

Competitive Landscape

ViaDerma competes directly with mass-market OTC topical antibiotics like Neosporin (J&J) and Polysporin (GSK), as well as generic bacitracin ointments. It positions itself as a premium, technologically superior alternative. It also indirectly competes with advanced prescription wound care products and antimicrobial dressings in professional care settings.

More companies in Small Molecule Drugs →More companies in United States →